Unique ID issued by UMIN | UMIN000032426 |
---|---|
Receipt number | R000036977 |
Scientific Title | Phase II study of narrow band ultraviolet therapy for treatment-refractory skin graft versus host disease complicated with allogeneic hematopoietic stem cell transplantation |
Date of disclosure of the study information | 2018/09/01 |
Last modified on | 2023/11/03 12:54:20 |
Phase II study of narrow band ultraviolet therapy for treatment-refractory skin graft versus host disease complicated with allogeneic hematopoietic stem cell transplantation
Phase II study of NBUV for skin GVHD
Phase II study of narrow band ultraviolet therapy for treatment-refractory skin graft versus host disease complicated with allogeneic hematopoietic stem cell transplantation
Phase II study of NBUV for skin GVHD
Japan |
skin GVHD
Hematology and clinical oncology | Dermatology |
Others
NO
Investigation of the effect and safety of the narrow band ultraviolet B (NBUVB) for treatment-resistant acute and/or chronic GVHD
Efficacy
Confirmatory
Pragmatic
Phase II
Overall response rate
1. Rates for complete response, partial response, stable disease, and progressive disease
2. Duration of response
3. Sparing effect on calcineurin inhibitor and corticosteroid
4. Adverse event(s)
5. Profile of immune cells
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
NO
NO
Institution is not considered as adjustment factor.
NO
No need to know
1
Treatment
Device,equipment |
Narrow band ultraviolet B therapy
16 | years-old | <= |
70 | years-old | >= |
Male and Female
1. Patient who receives treatment between April 1st 2018 and March 31st 2023
2. post-allogeneic hematopoietic stem cell transplantation patient with acute or chronic skin GVHD which is refractory to calcineurin inhibitor and/or corticosteroid treatment (not excluding patient who has GVHD in other tissues in addition to skin)
3. Patient who is able to have written informed consent for the study enrollment
4. Age between 16 to 70 at the informed consent
5. No restriction for gender
6. Performance status 0-2 defined by Eastern Cooperative Oncology Group criteria
1. Pregnant female patient
2. Poor control diabetes mellitus
3. Any severe infection
4. Treatment-difficult skin disease other than GVHD
5. Patients whom an attending physician consider not appropriate for study enrollment
40
1st name | JUNYA |
Middle name | |
Last name | KURODA |
Kyoto Prefectural University of Medicine
Division of Hematology and Oncology
602-8566
465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, JAPAN
0752515740
junkuro@koto.kpu-m.ac.jp
1st name | JUNYA |
Middle name | |
Last name | KURODA |
Kyoto Prefectural University of Medicine
Division of Hematology and Oncology
602-8566
465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, JAPAN
0752515740
junkuro@koto.kpu-m.ac.jp
Kyoto Prefectural University of Medicine
Kyoto Prefectural University of Medicine
Other
JAPAN
Kyoto Prefectural University of Medicine, Clinical Research Review Board
465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, JAPAN
075-251-5337
rinri@koto.kpu-m.ac.jp
NO
2018 | Year | 09 | Month | 01 | Day |
Unpublished
Enrolling by invitation
2018 | Year | 04 | Month | 30 | Day |
2018 | Year | 09 | Month | 18 | Day |
2018 | Year | 12 | Month | 18 | Day |
2027 | Year | 03 | Month | 31 | Day |
2018 | Year | 04 | Month | 30 | Day |
2023 | Year | 11 | Month | 03 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036977
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |